NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I'd prefer topline before ASCO, with further buildup to ASCO, all programs discussed at ASCO, BLA filed before SNO (if trial successful), then analysis (including longterm follow up) discussed at SNO, followed (hopefully) by approval. If it's successful, it's time to get this to patients. So sick of seeing artificial nature of business preempt translation of clinical medicine to patients. Shorts will not pile on, under your scenario, if no results announced at ASCO. The risk is too high and potential gain too little for them, and they are typically not stupid.